| |
2017
|
2009
|
|---|
|
Age-standardized prevalence rate (95% CI)
|
Age-standardized prevalence rate (95% CI)
|
|---|
|
Metabolic syndrome
|
|
Male
|
45.7 (42.9, 48.5)
|
34.6 (31.4, 37.8)
|
|
Female
|
44.5 (43.0, 46.1)
|
39.8 (38.1, 41.5)
|
|
Total
|
44 (42.7, 45.4)
|
38.0 (36.5, 39.5)
|
|
Central obesity
| | |
|
Male
|
60.4 (57.6, 63.2)
|
41.5 (38.0, 45.1)
|
|
Female
|
75.6 (74.2, 77.0)
|
60.1 (58.2, 61.9)
|
|
Total
|
70.9 (69.6, 72.3)
|
55.2 (53.5, 56.9)
|
|
High fasting blood glucose
|
|
Male
|
39.2 (36.6, 41.8)
|
28.7 (25.8, 31.6)
|
|
Female
|
32.4 (30.9, 33.9)
|
23.9 (22.3, 25.5)
|
|
Total
|
34.2 (32.9, 35.5)
|
25.1 (23.7, 26.4)
|
|
Elevated blood pressure
|
|
Male
|
46.7 (44.0, 49.5)
|
47.2 (43.5, 50.8)
|
|
Female
|
37.7 (36.2, 39.2)
|
38.6 (37.0, 40.3)
|
|
Total
|
39.8 (38.5, 41.1)
|
40.2 (38.7, 41.6)
|
|
Elevated triglycerides
|
|
Male
|
50.1 (47.3, 53.1)
|
54.4 (50.4, 58.3)
|
|
Female
|
35.1 (33.4, 36.7)
|
40.0 (38.1, 42.0)
|
|
Total
|
38.5 (37.1, 39.9)
|
42.7 (41.0, 44.4)
|
|
Low HDL
|
|
Male
|
59.2 (56.2, 62.3)
|
70.0 (66.1, 73.8)
|
|
Female
|
57.4 (55.5, 59.2)
|
64.7 (62.7, 66.7)
|
|
Total
|
57.7 (56.1, 59.3)
|
65.7 (64.0, 67.5)
|
|
HDL high-density lipoprotein
| | |
